Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Stock
Equities
300760
CNE100003G67
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 180.57 CNY | +0.13% |
|
+2.74% | -5.19% |
| Capitalization | 218B 31.8B 27.48B 24.81B 23.73B 43.25B 2,933B 44.46B 293B 117B 1,402B 119B 117B 5,051B | P/E ratio 2025 * |
22.8x | P/E ratio 2026 * | 19.9x |
|---|---|---|---|---|---|
| Enterprise value | 198B 28.82B 24.9B 22.48B 21.5B 39.19B 2,658B 40.29B 266B 106B 1,271B 108B 106B 4,577B | EV / Sales 2025 * |
5.78x | EV / Sales 2026 * | 5.13x |
| Free-Float |
42.59% | Yield 2025 * |
2.9% | Yield 2026 * | 3.21% |
| 1 day | +0.13% | ||
| 1 week | +2.74% | ||
| Current month | -2.88% | ||
| 1 month | -4.57% | ||
| 3 months | -7.76% | ||
| 6 months | -25.92% | ||
| Current year | -5.19% |
| 1 week | 175.5 |  | 182.25 |
| 1 month | 175.5 | | 189.99 |
| Current year | 175.5 | | 214.12 |
| 1 year | 175.5 | | 257 |
| 3 years | 175.5 | | 351.6 |
| 5 years | 175.5 | | 502 |
| 10 years | 58.56 | | 503.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Wu
CEO | Chief Executive Officer | 54 | 17/11/2020 |
Yun Zhao
DFI | Director of Finance/CFO | 43 | 15/11/2019 |
Yan Mei Guo
PRN | Corporate Officer/Principal | 63 | 27/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Hang Xu
CHM | Chairman | 64 | 25/01/1999 |
Xi Ting Li
CHM | Chairman | 75 | 18/12/2001 |
Ming He Cheng
BRD | Director/Board Member | 65 | 05/01/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.13% | +2.74% | -26.33% | -41.71% | 31.8B | |
| -0.87% | -3.31% | -3.59% | -8.85% | 184B | |
| +1.44% | -1.66% | -0.17% | +119.30% | 175B | |
| -0.08% | -4.72% | -5.13% | -18.64% | 138B | |
| -0.47% | -3.57% | -27.10% | +49.81% | 103B | |
| -1.68% | -5.07% | -23.76% | -22.31% | 50.76B | |
| -0.80% | -0.15% | +24.42% | +14.46% | 49.42B | |
| -2.82% | -7.30% | +6.36% | +16.66% | 34.83B | |
| -0.11% | -8.06% | -15.12% | -3.09% | 33.11B | |
| -0.01% | -4.25% | -4.64% | -14.96% | 32.62B | |
| Average | -0.42% | -3.56% | -7.51% | +9.07% | 83.3B | |
| Weighted average by Cap. | -0.16% | -3.32% | -6.56% | +24.10% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 34.21B 4.98B 4.3B 3.89B 3.72B 6.78B 459B 6.97B 45.94B 18.31B 220B 18.69B 18.3B 791B | 37.92B 5.52B 4.77B 4.31B 4.12B 7.51B 509B 7.72B 50.92B 20.3B 243B 20.72B 20.28B 877B |
| Net income | 9.6B 1.4B 1.21B 1.09B 1.04B 1.9B 129B 1.95B 12.89B 5.14B 61.64B 5.25B 5.13B 222B | 10.98B 1.6B 1.38B 1.25B 1.19B 2.17B 147B 2.24B 14.74B 5.88B 70.49B 6B 5.87B 254B |
| Net Debt | -20.48B -2.98B -2.58B -2.33B -2.23B -4.06B -275B -4.17B -27.51B -10.96B -132B -11.19B -10.96B -474B | -23.87B -3.48B -3B -2.71B -2.59B -4.73B -321B -4.86B -32.06B -12.78B -153B -13.04B -12.77B -552B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/03/26 | 180.57 ¥ | +0.13% | 5,140,947 |
| 10/03/26 | 180.34 ¥ | +0.87% | 3,938,799 |
| 09/03/26 | 178.78 ¥ | -1.43% | 5,866,763 |
| 06/03/26 | 181.37 ¥ | +2.93% | 7,638,494 |
| 05/03/26 | 176.20 ¥ | +0.26% | 5,098,138 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300760 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition